Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$209.01 - $232.56 $940,545 - $1.05 Million
-4,500 Reduced 44.51%
5,610 $1.23 Million
Q3 2023

Oct 27, 2023

SELL
$201.05 - $221.7 $70,367 - $77,595
-350 Reduced 3.35%
10,110 $2.03 Million
Q1 2023

May 08, 2023

BUY
$213.32 - $257.83 $142,924 - $172,746
670 Added 6.84%
10,460 $2.4 Million
Q4 2022

Jan 31, 2023

BUY
$203.72 - $248.97 $16,297 - $19,917
80 Added 0.82%
9,790 $2.3 Million
Q2 2022

Aug 04, 2022

BUY
$213.86 - $277.87 $21,386 - $27,787
100 Added 1.04%
9,710 $2.28 Million
Q1 2022

May 02, 2022

BUY
$259.82 - $298.18 $116,919 - $134,181
450 Added 4.91%
9,610 $2.53 Million
Q2 2021

Aug 13, 2021

SELL
$251.87 - $278.14 $100,748 - $111,256
-400 Reduced 4.18%
9,160 $2.53 Million
Q1 2021

Apr 28, 2021

BUY
$204.88 - $255.03 $40,976 - $51,006
200 Added 2.14%
9,560 $2.44 Million
Q4 2020

Feb 09, 2021

BUY
$186.91 - $214.42 $37,382 - $42,884
200 Added 2.18%
9,360 $1.91 Million
Q3 2020

Nov 06, 2020

SELL
$167.03 - $201.3 $8,351 - $10,065
-50 Reduced 0.54%
9,160 $1.73 Million
Q2 2020

Aug 12, 2020

SELL
$113.31 - $182.44 $56,655 - $91,220
-500 Reduced 5.15%
9,210 $1.53 Million
Q1 2020

Apr 28, 2020

BUY
$104.32 - $195.28 $10,432 - $19,528
100 Added 1.04%
9,710 $1.23 Million
Q4 2019

Feb 05, 2020

BUY
$163.48 - $173.61 $32,695 - $34,722
200 Added 2.13%
9,610 $1.63 Million
Q4 2018

Jan 25, 2019

SELL
$120.82 - $174.09 $24,164 - $34,818
-200 Reduced 2.08%
9,410 $1.19 Million
Q3 2018

Nov 07, 2018

BUY
$167.67 - $188.27 $33,534 - $37,654
200 Added 2.13%
9,610 $1.67 Million
Q3 2017

Oct 26, 2017

BUY
$149.47 - $160.56 $1.41 Million - $1.51 Million
9,410
9,410 $1.42 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.4B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Montgomery Investment Management Inc Portfolio

Follow Montgomery Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montgomery Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montgomery Investment Management Inc with notifications on news.